Last updated on July 2019

Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors


Find a site near you

Start Over

University of Arizona

Tucson, AZ United States
  Connect »

Georgetown

Washington, WA United States
  Connect »

Johns Hopkins

Baltimore, MD United States
  Connect »

BIDMC

Boston, MA United States
  Connect »

DFCI

Boston, MA United States
  Connect »

Henry Ford

Detroit, MI United States
  Connect »

Vanderbilt

Nashville, TN United States
  Connect »

MD Anderson

Houston, TX United States
  Connect »

START

San Antonio, TX United States
  Connect »

NKI

Amsterdam, Netherlands
  Connect »

Radboudumc

Nijmegen, Netherlands
  Connect »